Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $4.94 Billion |
|---|---|
| Enterprise Value | $6.64 Billion |
| Annual dividend | $0.86 |
| Dividend yield | 3.88% |
| Earnings per Share | $1.86 |
| Beta | 0.65 |
| Outstanding Shares | 211,747,090 |
| P/E Ratio | 12.07 |
|---|---|
| PEG | -190.94 |
| Price to Sales | 0.71 |
| Price to Book Ratio | 2.0 |
| Enterprise Value to Revenue | 1 |
| Enterprise Value to EBIT | 5.33 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 0.78 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in var...